FITC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
11 reviews
Product Citations
publications
53-6.7_FITC_102110
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
  • 53-6.7_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
See FITC spectral data
Cat # Size Price Quantity Avail. Save
100705 50 µg 20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100706 500 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, and immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 μm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
Product Citations
  1. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  2. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  3. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  4. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  5. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  6. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  7. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  8. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  9. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  10. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  11. Morales D, et al. 2015. J Virol. 89:337. PubMed
  12. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  13. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  14. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  15. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  16. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  17. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  18. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  19. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  20. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  21. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  22. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  23. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  24. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  25. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  26. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  27. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  28. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  29. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  30. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  31. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  32. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  33. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  34. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  35. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  36. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  37. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  38. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  39. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  40. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  41. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  42. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  43. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  44. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  45. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  46. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  47. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  48. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  49. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  50. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  51. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  52. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  53. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  54. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  55. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  56. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  57. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  58. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  59. Wan X, et al. 2018. Nature. 560:107. PubMed
  60. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  61. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  62. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  63. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  64. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  65. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  66. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  67. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  68. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  69. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  70. Liu J, et al. 2019. Immunity. 50:600. PubMed
  71. Du J, et al. 2018. AMB Express. 8:158. PubMed
  72. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  73. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  74. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  75. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  76. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  77. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  78. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  79. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  80. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  81. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  82. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  83. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
RRID
AB_312744 (BioLegend Cat. No. 100705)
AB_312745 (BioLegend Cat. No. 100706)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 01.21.2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Forgot your password? Reset password?
Create an Account